Reyataz and Dacryocanaliculitis - from FDA reports


There is no Dacryocanaliculitis reported by people who take Reyataz yet. This review analyzes which people have Dacryocanaliculitis with Reyataz. It is created by eHealthMe based on reports from FDA, and is updated regularly.

What to expect?

If you take Reyataz and have Dacryocanaliculitis, find out what symptoms you could have in 1 year or longer.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Dec, 14, 2017

No report is found.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Dacryocanaliculitis when taking Reyataz?

Expand the study to include all drugs with the same ingredients

Dacryocanaliculitis and drugs with ingredients of atazanavir sulfate.

Expand the study to include reports from both FDA and eHealthMe

Dacryocanaliculitis and Reyataz from FDA and eHealthMe reports


Reyataz has active ingredients of atazanavir sulfate. It is often used in hiv infection. (latest outcomes from Reyataz 8,724 users)


Dacryocanaliculitis (1. inflammation of the lacrimal ducts. 2. inflammation of the lacrimal sac and lacrimal canaliculi) has been reported by people with rheumatoid arthritis, osteopenia, osteoporosis, cystitis interstitial, keratitis fungal (latest reports from 63 Dacryocanaliculitis patients).

Browse all side effects of Reyataz

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Dacryocanaliculitis


Could your condition cause Dacryocanaliculitis


Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Reyataz and have Dacryocanaliculitis.

User reviews to the study

More reviews >